IRIS Accounts Production v26.3.0.614 14716824 director 1.1.25 31.12.25 31.12.25 false true false false false false false true false Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh147168242024-12-31147168242025-12-31147168242025-01-012025-12-31147168242023-12-31147168242024-01-012024-12-31147168242024-12-3114716824ns15:EnglandWales2025-01-012025-12-3114716824ns14:PoundSterling2025-01-012025-12-3114716824ns10:Director12025-01-012025-12-3114716824ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3114716824ns10:SmallEntities2025-01-012025-12-3114716824ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3114716824ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3114716824ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3114716824ns10:FullAccounts2025-01-012025-12-3114716824ns5:Associate12025-01-012025-12-3114716824ns5:Associate22025-01-012025-12-3114716824ns5:Associate32025-01-012025-12-3114716824ns10:OrdinaryShareClass12025-01-012025-12-3114716824ns10:RegisteredOffice2025-01-012025-12-3114716824ns5:CurrentFinancialInstruments2025-12-3114716824ns5:CurrentFinancialInstruments2024-12-3114716824ns5:ShareCapital2025-12-3114716824ns5:ShareCapital2024-12-3114716824ns5:RetainedEarningsAccumulatedLosses2025-12-3114716824ns5:RetainedEarningsAccumulatedLosses2024-12-3114716824ns5:CostValuationns5:ListedExchangeTraded2024-12-3114716824ns5:AdditionsToInvestments2025-12-3114716824ns5:AdditionsToInvestmentsns5:ListedExchangeTraded2025-12-3114716824ns5:RevaluationsIncreaseDecreaseInInvestments2025-12-3114716824ns5:RevaluationsIncreaseDecreaseInInvestmentsns5:ListedExchangeTraded2025-12-3114716824ns5:CostValuation2025-12-3114716824ns5:CostValuationns5:ListedExchangeTraded2025-12-3114716824ns5:ListedExchangeTraded2025-12-3114716824ns5:ListedExchangeTraded2024-12-3114716824ns5:Associate112025-01-012025-12-3114716824ns5:Associate12025-12-3114716824ns5:Associate12024-12-3114716824ns5:Associate12024-01-012024-12-31147168243ns5:Associate22025-01-012025-12-3114716824ns5:Associate22025-12-3114716824ns5:Associate22024-12-3114716824ns5:Associate22024-01-012024-12-3114716824ns5:Associate352025-01-012025-12-3114716824ns5:Associate32025-12-3114716824ns5:Associate32024-12-3114716824ns5:Associate32024-01-012024-12-3114716824ns10:OrdinaryShareClass12025-12-3114716824ns5:RetainedEarningsAccumulatedLosses2024-12-3114716824ns5:RetainedEarningsAccumulatedLosses2025-01-012025-12-31
REGISTERED NUMBER: 14716824 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

OCULAR HOLDINGS LIMITED

OCULAR HOLDINGS LIMITED (REGISTERED NUMBER: 14716824)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


OCULAR HOLDINGS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTOR: S J Carroll





REGISTERED OFFICE: 2 Jardine House
The Harrovian Business Village
Bessborough Road
Harrow
Middlesex
HA1 3EX





REGISTERED NUMBER: 14716824 (England and Wales)





ACCOUNTANTS: Barber & Company
A trading name of PCM Accounting Limited
2 Jardine House
Harrovian Business Village
Bessborough Road
Harrow
Middlesex
HA1 3EX

OCULAR HOLDINGS LIMITED (REGISTERED NUMBER: 14716824)

BALANCE SHEET
31 DECEMBER 2025

31.12.25 31.12.24
Notes £    £    £    £   
FIXED ASSETS
Investments 4 37,895,061 26,512,438

CREDITORS
Amounts falling due within one year 5 35,272,236 25,644,884
NET CURRENT LIABILITIES (35,272,236 ) (25,644,884 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,622,825

867,554

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 7 2,622,725 867,454
SHAREHOLDERS' FUNDS 2,622,825 867,554

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 October 2026 and were signed by:





S J Carroll - Director


OCULAR HOLDINGS LIMITED (REGISTERED NUMBER: 14716824)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

Ocular Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

INVESTMENTS IN ASSOCIATES
Investments in associate undertakings are recognised at cost.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

LISTED INVESTMENTS
Listed Investments are stated at fair value (market value) at each reporting date.

Changes in fair value (gains / losses) are recognised within the Profit and Loss Account.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

OCULAR HOLDINGS LIMITED (REGISTERED NUMBER: 14716824)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

4. FIXED ASSET INVESTMENTS
Interest
in Listed
associate investments Totals
£    £    £   
COST OR VALUATION
At 1 January 2025 130,125 26,382,313 26,512,438
Additions 77,274 10,045,061 10,122,335
Revaluations - 1,260,288 1,260,288
At 31 December 2025 207,399 37,687,662 37,895,061
NET BOOK VALUE
At 31 December 2025 207,399 37,687,662 37,895,061
At 31 December 2024 130,125 26,382,313 26,512,438

Cost or valuation at 31 December 2025 is represented by:

Interest
in Listed
associate investments Totals
£    £    £   
Valuation in 2024 - 647,444 647,444
Valuation in 2025 - 1,260,288 1,260,288
Cost 207,399 35,779,930 35,987,329
207,399 37,687,662 37,895,061

The company's investments at the Balance Sheet date in the share capital of companies include the following:

ASSOCIATED COMPANIES

Constantinople Spice Consortium Limited
Registered office: 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex, HA1 3EX.
Nature of business: Trading
%
Class of shares: holding
Ordinary Shares 50.00
31.12.25 31.12.24
£    £   
Aggregate capital and reserves (464,114 ) (423,246 )
Loss for the year (40,768 ) (58,118 )

OCULAR HOLDINGS LIMITED (REGISTERED NUMBER: 14716824)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

4. FIXED ASSET INVESTMENTS - continued

Namayan Spirits Limited
Registered office: 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex, HA1 3EX.
Nature of business: Trading
%
Class of shares: holding
Ordinary Shares 36.80
31.12.25 31.12.24
£    £   
Aggregate capital and reserves (1,824,469 ) (1,199,411 )
Loss for the year (625,068 ) (470,625 )

Deviation Spirits Limited
Registered office: 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex, HA1 3EX
Nature of business: Investment Holding
%
Class of shares: holding
Ordinary Shares 40.50
31.12.25 31.12.24
£    £   
Aggregate capital and reserves 377,976 306,648
Loss for the year (3,361 ) (13,352 )

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Corporation tax 137,237 74,857
Social security and other taxes 352 352
Directors' current accounts 35,099,715 25,564,075
Accruals and deferred income 34,932 5,600
35,272,236 25,644,884

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.25 31.12.24
value: £    £   
100 Ordinary Shares £1 100 100

7. RESERVES
Retained
earnings
£   

At 1 January 2025 867,454
Profit for the year 1,755,271
At 31 December 2025 2,622,725

OCULAR HOLDINGS LIMITED (REGISTERED NUMBER: 14716824)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

8. CONTROLLING PARTY

The controlling party is S J Carroll.